Tsung‐I Hsu

3.1k total citations
87 papers, 2.4k citations indexed

About

Tsung‐I Hsu is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Tsung‐I Hsu has authored 87 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 20 papers in Genetics and 14 papers in Cancer Research. Recurrent topics in Tsung‐I Hsu's work include Glioma Diagnosis and Treatment (19 papers), Histone Deacetylase Inhibitors Research (11 papers) and RNA Research and Splicing (8 papers). Tsung‐I Hsu is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Histone Deacetylase Inhibitors Research (11 papers) and RNA Research and Splicing (8 papers). Tsung‐I Hsu collaborates with scholars based in Taiwan, United States and Germany. Tsung‐I Hsu's co-authors include Jan‐Jong Hung, Jian‐Ying Chuang, Wen‐Chang Chang, Wen‐Bin Yang, Wu‐Chou Su, Tzu‐Jen Kao, Chiung‐Yuan Ko, Chia-Yang Hung, Shao‐An Wang and R U Simpson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Tsung‐I Hsu

84 papers receiving 2.4k citations

Peers

Tsung‐I Hsu
Cong Cao China
Bin Feng China
Julia Kargl Austria
Sarah Wright United States
Dohoon Kim United States
Anthony J. Milici United States
Chi Ma United States
Cong Cao China
Tsung‐I Hsu
Citations per year, relative to Tsung‐I Hsu Tsung‐I Hsu (= 1×) peers Cong Cao

Countries citing papers authored by Tsung‐I Hsu

Since Specialization
Citations

This map shows the geographic impact of Tsung‐I Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐I Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐I Hsu more than expected).

Fields of papers citing papers by Tsung‐I Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐I Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐I Hsu. The network helps show where Tsung‐I Hsu may publish in the future.

Co-authorship network of co-authors of Tsung‐I Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐I Hsu. A scholar is included among the top collaborators of Tsung‐I Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐I Hsu. Tsung‐I Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Chih‐Jie, Amandeep Thakur, I‐Chung Chen, et al.. (2025). Contribution of Prostaglandin E2‐Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative. Advanced Science. 12(38). e06336–e06336. 1 indexed citations
3.
Lin, Hong-Yi, et al.. (2024). Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease. The Journal of Steroid Biochemistry and Molecular Biology. 243. 106585–106585. 2 indexed citations
4.
Lin, Hong-Yi, et al.. (2024). Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma. Journal of Experimental & Clinical Cancer Research. 43(1). 218–218. 2 indexed citations
5.
Qian, Bin, Mei‐Jung Lai, Tsung‐I Hsu, et al.. (2023). Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. European Journal of Medicinal Chemistry. 256. 115459–115459. 13 indexed citations
6.
Li, Hao‐Yi, et al.. (2023). Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma. Mitochondrion. 75. 101836–101836. 7 indexed citations
7.
Chiang, I‐Tsang, Yu‐Chang Liu, Huashan Liu, et al.. (2022). Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma. Neurotherapeutics. 19(2). 616–634. 19 indexed citations
8.
Hsu, Tsung‐I, et al.. (2020). L-selectin activation regulates Rho GTPase activity via Ca+2 influx in Sertoli cell line, ASC-17D cells. Biochemical and Biophysical Research Communications. 525(4). 1011–1017. 5 indexed citations
9.
Chien, Chia-Hung, Jian‐Ying Chuang, Shun‐Tai Yang, et al.. (2019). Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets. Journal of Biomedical Science. 26(1). 77–77. 29 indexed citations
10.
Lin, Hsin-Chuan, Chiung‐Yuan Ko, Kuen‐Haur Lee, et al.. (2019). E2f1 regulates the induction of promyelocytic leukemia zinc finger transcription in neuronal differentiation of pluripotent P19 embryonal carcinoma cells. Biochemical and Biophysical Research Communications. 512(3). 629–634. 3 indexed citations
11.
Lin, Ching‐Yu, Shun‐Tai Yang, Shing‐Chuan Shen, et al.. (2018). Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression. Molecular Oncology. 12(5). 756–771. 27 indexed citations
12.
Chou, Szu‐Yi, Chi‐Chen Huang, Jian‐Ying Chuang, et al.. (2018). Ephexin1 Is Required for Eph-Mediated Limb Trajectory of Spinal Motor Axons. Journal of Neuroscience. 38(8). 2043–2056. 9 indexed citations
13.
Ko, Chiung‐Yuan, et al.. (2017). MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance. Molecular Neurobiology. 55(4). 3211–3223. 18 indexed citations
14.
Chang, Kwang‐Yu, Tsung‐I Hsu, Cheng‐Keng Chuang, et al.. (2017). Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma. Biochemical and Biophysical Research Communications. 493(1). 14–19. 25 indexed citations
15.
Hung, Chia-Yang, Wen‐Bin Yang, Shao‐An Wang, et al.. (2014). Nucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(12). 2843–2854. 23 indexed citations
17.
Tseng, Philip, Tsung‐I Hsu, Ovid J. L. Tzeng, et al.. (2012). Unleashing Potential: Transcranial Direct Current Stimulation over the Right Posterior Parietal Cortex Improves Change Detection in Low-Performing Individuals. Journal of Neuroscience. 32(31). 10554–10561. 214 indexed citations
18.
Hsu, Tsung‐I, et al.. (2011). Sp1 expression regulates lung tumor progression. Oncogene. 31(35). 3973–3988. 121 indexed citations
19.
Liu, Yi‐Wen, et al.. (2010). Inhibition of LPS‐induced C/EBPδ by trichostatin a has a positive effect on LPS‐induced cyclooxygenase 2 expression in RAW264.7 cells. Journal of Cellular Biochemistry. 110(6). 1430–1438. 11 indexed citations
20.
Hsu, Tsung‐I, et al.. (1996). Functional analysis of C-terminal deletion mutants of Epstein--Barr virus thymidine kinase. Journal of General Virology. 77(8). 1893–1899. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026